Publication | Open Access
Wide Spectrum of Inhibitory Effects of Sertraline on Cardiac Ion Channels
39
Citations
26
References
2012
Year
Cardiac MuscleHeart FailureSynaptic TransmissionCardiovascular PharmacologyWide SpectrumCardiac KPharmacotherapyExperimental PharmacologySocial SciencesMolecular PharmacologyHyperpolarization (Biology)CardiologyIon ChannelsNeuropharmacologyPharmacologyPotassium HomeostasisInhibitory NeurotransmittersCardiac Ion ChannelsInhibitory EffectsNeurophysiologyPhysiologyRank OrderElectrophysiologyCardiovascular PhysiologyMedicine
Sertraline is a commonly used antidepressant of the selective serotonin reuptake inhibitors (SSRIs) class. In these experiments, we have used the whole cell patch clamp technique to examine the effects of sertraline on the major cardiac ion channels expressed in HEK293 cells and the native voltage-gated Ca(2+) channels in rat ventricular myocytes. According to the results, sertraline is a potent blocker of cardiac K(+) channels, such as hERG, I(Ks) and I(K1). The rank order of inhibitory potency was hERG >I(K1)> I(Ks) with IC(50) values of 0.7, 10.5, and 15.2 µM, respectively. In addition to K(+) channels, sertraline also inhibited I(Na) and I(Ca), and the IC(50) values are 6.1 and 2.6 µM, respectively. Modification of these ion channels by sertraline could induce changes of the cardiac action potential duration and QT interval, and might result in cardiac arrhythmia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1